Company Aimmune Therapeutics, Inc.
Equities
AIMT
US00900T1079
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Compliance Officer | 57 | 20-09-30 | |
Jim Pepin
LAW | General Counsel | - | - |
Samina Bari
PRN | Corporate Officer/Principal | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 65,450,142 | 50,930,993 ( 77.82 %) | 0 | 77.82 % |
Company contact information
Aimmune Therapeutics, Inc.
1007 US Highway 202/206 Building JR2
08807, Bridgewater
+650 614 5220
http://www.aimmune.comSector
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.79% | 22.02B | |
-17.84% | 20.9B | |
-11.11% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |